Trial intelligence / Profile preview

Population pharmacokinetic modeling of mitotane in adults with adrenocortical carcinoma

NL-OMON37374Active, not recruiting

Sponsor
Máxima Medisch Centrum
Start
Jun 2012
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of mitotane in adrenal cancer (ACC), sponsored by Máxima Medisch Centrum. Primary endpoints: Observed mitotane plasma levels, Mitotane doses administered and 2 more. Started Jun 2012; status: active, not recruiting.

02

Drugs

mitotane
03

Conditions

adrenal cancer (ACC)

Beyond the preview

Go deeper on NL-OMON37374.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON37374.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call